Subscriber access provided by UniSA Library
Article
Haloacetic Acid Water Disinfection By-Products Affect Pyruvate Dehydrogenase Activity and Disrupt Cellular Metabolism AZRA DAD, Clara Hyunhee Jeong, Elizabeth D. Wagner, and Michael J Plewa Environ. Sci. Technol., Just Accepted Manuscript • DOI: 10.1021/acs.est.7b04290 • Publication Date (Web): 20 Dec 2017 Downloaded from http://pubs.acs.org on December 24, 2017
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Environmental Science & Technology is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 29
Environmental Science & Technology
HALOACETIC ACID WATER DISINFECTION BY-PRODUCTS AFFECT PYRUVATE DEHYDROGENASE ACTIVITY AND DISRUPT CELLULAR METABOLISM
Azra Dad1**,*, Clara H. Jeong2,3 , Elizabeth D. Wagner1, Michael J. Plewa1
1. Safe Global Water Institute, University of Illinois at Urbana-Champaign and the Department of Crop Sciences, University of Illinois at Urbana-Champaign. 2. Molecular and Environmental Toxicology Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. 3. Department of Urology, University of Wisconsin-Madison, Madison, WI, USA.
**Current address: Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA
*Corresponding Author: Azra Dad, nfn.azra@fda.hhs.gov
ACS Paragon Plus Environment
1
Environmental Science & Technology
Page 2 of 29
1
ABSTRACT
2
The disinfection of drinking water has been a major public health achievement. However,
3
haloacetic acids (HAAs), generated as by-products of water disinfection, are cytotoxic,
4
genotoxic, mutagenic, carcinogenic and teratogenic. Previous studies of monoHAA-
5
induced genotoxicity and cell stress demonstrated that the toxicity was due to inhibition
6
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) leading to disruption of cellular
7
metabolism and energy homeostasis. DiHAAs and triHAAs are also produced during
8
water disinfection, and whether they share mechanisms of action with monoHAAs is
9
unknown. In this study, we evaluated the effects of mono-, di-, and tri-HAAs on cellular
10
GAPDH enzyme kinetics, cellular ATP levels, and pyruvate dehydrogenase complex
11
(PDC) activity. Here, treatments conducted in Chinese hamster ovary (CHO) cells
12
revealed differences among mono-, di-, and triHAAs in their molecular targets. The
13
monoHAAs, iodoacetic acid and bromoacetic acid, were the strongest inhibitors of
14
GAPDH and greatly reduced cellular ATP levels. Chloroacetic acid, diHAAs and
15
triHAAs were weaker inhibitors of GAPDH and some increased the levels of cellular
16
ATP. HAAs also affected PDC activity, with most HAAs activating PDC. The primary
17
finding of this work is that mono- versus multihalo HAAs address different molecular
18
targets and the results are generally consistent with a model in which monoHAAs
19
activate the PDC through GAPDH inhibition-mediated disruption in cellular metabolites,
20
including altering ATP:ADP and NADH:NAD ratios. The monoHAA-mediated
21
reduction in cellular metabolites results in accelerated PDC activity by way of
22
metabolite-ratio-dependent PDC regulation. DiHAAs and triHAAs are weaker inhibitors
23
of GAPDH, but many also increase cellular ATP levels, and we suggest that they increase
24
PDC activity by inhibiting pyruvate dehydrogenase kinase.
ACS Paragon Plus Environment
2
Page 3 of 29
Environmental Science & Technology
25 26
INTRODUCTION Disinfection of drinking water was one of the major public health achievements of
27
the 20th century, significantly reducing the outbreak of water-borne diseases including
28
cholera, typhoid and dysentery.1 Disinfectants are oxidants that not only kill pathogenic
29
microorganisms but also generate disinfection by-products (DBPs). 2 Currently over 600
30
DBPs have been identified.3 In chlorinated water, the second largest DBP chemical class
31
is the haloacetic acids (HAAs).4, 5 The U.S. Environmental Protection Agency (EPA)
32
regulates five HAAs (chloroacetic acid (CAA), dichloroacetic acid (DCA),
33
trichloroacetic acid (TCA), bromoacetic acid (BAA), and dibromoacetic acid (DBA)) to a
34
total maximum contaminant level of 60 µg/L.6
35
HAAs as a class of DBPs expressed different levels and types of toxicity based on
36
their chemical structures.3, 7-11 DBP exposure is associated with increased risks of bladder
37
and colorectal cancer,9 and spontenous abortion and other negative pregnancy
38
outcomes.10 DCA, TCA, and DBA induced hepatocellular adenomas and hepatocellular
39
carcinomas in B6C3F1 mice and F344 rats11, and gestational exposure of a mixture of
40
regulated HAAs resulted in pregnancy loss and eye malformation in rats.8 HAAs were
41
cytotoxic and genotoxic in Chinese hamster ovary (CHO) cells 12, mutagenic in
42
Salmonella typhimurium and CHO cells,13-15 and cytotoxic and genotoxic in primary
43
human cells.16 Results from in vitro studies have provided information on the molecular
44
mode of toxicity mechanisms of monoHAAs.16-18
45 46
HAAs are SN2 alkylating agents15 and thus capable of binding cellular macromolecules. Previously, we demonstrated that monoHAAs do not directly damage
ACS Paragon Plus Environment
3
Environmental Science & Technology
Page 4 of 29
47
DNA, but inhibit glyceraldehyde 3-phosphate dehydrogenase (GAPDH), by alkylating
48
the sulfhydryl group of the cysteine residue in the active site, rendering the enzyme
49
inactive.16, 18 GAPDH is a pivotal enzyme in glycolysis and the HAA-induced inhibition
50
of GAPDH activity can affect pyruvate generation, which is required by mitochondrial
51
metabolism. Alterations in mitochondrial metabolism can lead to elevated levels of
52
reactive oxygen species (ROS) that can damage DNA.19, 20 Treating cells with exogenous
53
pyruvate overcame the monoHAA –mediated reduction in cellular ATP and reduced
54
genomic DNA damage.17 We hypothesized that di-, and triHAAs may follow the same
55
toxicity pathway by inhibiting GAPDH and reducing cellular ATP levels. Previous
56
studies demonstrated that DCA was used as a treatment for patients with lactic acidosis as
57
a result of pyruvate dehydrogenase (PDH) deficiency. 21 DCA also has been used as a
58
chemotherapeutic agent because it reverses the Warburg effect 22 by activating PDH
59
through inhibition of PDH kinase. 21, 23-25
60
The pyruvate dehydrogenase complex (PDC) is a multi-enzyme complex 26 that is
61
responsible for catalyzing the conversion of pyruvate, NAD+, and coenzyme-A into
62
acetyl-CoA, NADH and CO2 in the presence of thiamine pyrophosphate and Mg+2.27
63
Mammalian PDC is made up of multiple isoforms of 6 different components: pyruvate
64
dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2), dihydrolipoamide
65
dehydrogenase (E3), E1 specific kinases, phospho-E1 phosphotase, and X protein.26, 28
66
E1, E2, and E3 are the major catalytic components, and are responsible for the stepwise
67
decarboxylation and dehydrogenation of pyruvate into acetyl- CoA. 29
68 69
The E1 component of PDC is a tetramer (α2β2) with two thiamine pyrophosphate (TPP) binding sites. The E1α component is inactivated/phosphorylated by pyruvate
ACS Paragon Plus Environment
4
Page 5 of 29
Environmental Science & Technology
70
dehydrogenase kinase (PDK) and activated/dephosphorylated by phospho-E1-
71
phosphatase. Dephosphorylation by phospho-E1-phosphatase leads to the activation of
72
the enzyme.29, 30 E2, besides generating acetyl-CoA, also has L1 and L2 lipoyl domains
73
that facilitate the binding of PDK and phospho-E1-phosphatase and thus plays a crucial
74
role in the activation and inactivation of these enzymes. 29, 31
75
Kato and colleagues found that rat PDK2 had a unique component known as the
76
“ATP lid”. The binding of ATP lid to the L2 domain of PDC-E2 regulated PDK activity
77
by inducing allosteric conformational changes in the ATP lid changing its affinity for
78
ADP. They demonstrated that unbound ATP lid had a higher affinity for ADP, rendering
79
PDK inactive, and that bound ATP lid promoted PDK activity. 32
80
Kato and colleagues also found that DCA reduced PDK1 and PDK3 activity to
81
4% and 17% of the control, respectively.33 Bonnet and colleagues demonstrated that
82
DCA induced apoptosis in tumor cells by reversing the Warburg effect; DCA activated
83
the PDC by inhibiting PDK and shifting the glycolytic-based metabolism to mitochondria
84
in tumor cells.34
85
These studies indicated that the PDC is regulated by PDK. However, the cellular
86
ATP/ADP ratio also plays a significant role in regulating PDK, PDC and overall
87
mitochondrial metabolism.35
88
We propose that HAAs disrupt metabolism by activating PDC either by
89
inhibiting GAPDH or PDK, depending on the HAA halogenation level (mono-, di-, and
90
tri-HAAs). We also hypothesize that these two mechanisms of HAA-induced PDC
91
activation, through either GAPDH inhibition or PDK inhibition, operate independently.
ACS Paragon Plus Environment
5
Environmental Science & Technology
Page 6 of 29
92
To test this hypothesis, we conducted a series of studies in Chinese hamster ovary (CHO)
93
cells to (i) measure GAPDH inhibition following HAA-treatment; (ii) determine the
94
effect of HAA-treatment on PDC activity; and (iii) measure the impact of HAA exposure
95
on cellular ATP levels. CHO cells were employed in this study since they were used in
96
developing the largest database on chronic cell cytotoxicity and genomic DNA damage
97
induced by DBPs12.36
ACS Paragon Plus Environment
6
Page 7 of 29
Environmental Science & Technology
98
MATERIALS AND METHODS
99
Reagents
100
DBA, DCA, tribromoacetic acid (TBA), TCA, and CAA were purchased from
101
Fluka (St. Louis, MO); iodoacetic acid (IAA) and BAA were obtained from Sigma (St.
102
Louis, MO), dibromochloroacetic acid (BDCA) from Radian International (Austin, TX),
103
and DBCA from Cerilliant (Round Rock, TX); bromochloroacetic acid (BCA) was from
104
the U. S. EPA. Nutrient mixture F12 and fetal bovine serum (FBS) were purchased from
105
Fisher Scientific (Itasca, IL). Cell Titer-Glo reagent was obtained from Promega
106
(Madison, WI), and the Pyruvate Dehydrogenase (PDH) Activity Colorimetric Assay Kit
107
was purchased from BioVision (San Francisco, CA). Glyceraldehyde-3-phosphate was
108
purchased from Sigma-Aldrich (St. Louis, MO). Other reagents were obtained from
109
either Fisher Scientific or Sigma in the highest purities available. Stock HAA solutions
110
were dissolved in dimethylsulfoxide (DMSO) and stored at −20°C in sealed sterile glass
111
vials (Sulpelco, Bellefonte, PA). Working HAA solutions were diluted in Hank’s
112
balanced salt solution (HBSS) to the appropriate concentration.
113 114 115
CHO Cell Culture and HAA Treatment The CHO cell line AS52, clone 11-4-8 (derived from CHOK1 cells) was used in
116
all experiments. 37-39 Routine CHO cultures were maintained in 100-mm glass petri plates
117
containing F12 medium supplemented with 5% FBS, 1% glutamine and 1% antibiotic-
118
antimycotic (F12 complete medium) solution at 37°C in a humidified atmosphere of 5%
119
CO2 in air.
ACS Paragon Plus Environment
7
Environmental Science & Technology
120
Noncytotoxic concentrations of HAAs were used for treatments in order to
121
measure endpoints without the confounding factor of overt cytotoxicity. The test doses
122
were based on the dose response cytotoxicity data reported by Plewa et al. (2010)12 and
123
preliminary range-finding experiments conducted for this study (data not shown). When
124
the HAAs produced alterations in the endpoints that were measured (e.g., activation of
125
PDC), the lowest noncytotoxic doses producing significant responses were chosen for
126
making comparisons among HAAs.
127
GAPDH Enzyme Kinetics Analysis
128
Page 8 of 29
The GAPDH enzyme kinetics analysis method was adapted from (Pals et
129
al.2011).18 CHO cells were grown in F12 complete medium on 60-mm plastic cell culture
130
plates until the cells reached confluency. The medium was removed and the cells were
131
washed 3× with 2 mL cold phosphate-buffered saline (PBS) and once with 2 mL cold
132
Buffer K (1 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, pH 7.6). The cells then were
133
tumefied with Buffer K for 2 min at ambient temperature, followed by homogenization
134
with a sterilized cell scraper. The cell homogenates were collected in microfuge tubes,
135
centrifuged at 16,100 × g for 3 min at room temperature to remove cellular debris, and
136
the supernatants transferred to a fresh tube. Next, 854 µL of reaction buffer (0.1 M Tris-
137
HCl (pH 8.5), 5 mM KH2PO4, 20 mM NaF, 1.7 mM NaAsO2, and 1 mM NAD), and 220
138
µL of a 5× solution of the HAA test agents were added to 22 µL cell homogenates. The
139
mixture was vortexed, and incubated for 2 min, and 996.3 µL of the assay mixture was
140
transferred to a quartz spectrophotometer cuvette, and the instrument was zeroed at 340
141
nm. Finally, 3.7 µL of 1 mM glyceraldyde-3-phospate (G3P) was added to the assay
142
mixture to initiate the GAPDH-dependent NAD+ to NADH conversion; NADH
ACS Paragon Plus Environment
8
Page 9 of 29
Environmental Science & Technology
143
absorption was measured at 340 nm every 10 s for a total of 60 s using a Beckman
144
DU7400 UV-vis spectrophotometer. Each experiment included a negative control and
145
three replicates of all HAA test agent concentrations. Absorbance values were plotted
146
against time for each individual experiment and a linear regression was fitted to the data
147
to calculate the GAPDH kinetic rates. Cell homogenate protein levels were obtained as
148
described below. GAPDH activity was calculated as µMol NADH/min/µg protein. Data
149
were compared to the concurrent negative control for each experiment and the percent
150
reduction in the GAPDH activity per µM of each HAA was calculated. ANOVA with
151
Holm-Sidak pairwise comparisons were performed to compare the reduction in the
152
GAPDH activity among mono-, di- and triHAAs.
153
ATP Analysis and Protein Quantification
154
Parallel ATP and protein analyses were performed following HAA treatments.
155
Cellular ATP levels were measured using the Promega Cell Titer-Glo reagent in a 96-
156
well microplate assay and using a TUNE-SpectraMax Paradigm® Multi-Mode
157
Microplate Detection Platform. The day before ATP analysis, 3×104 CHO cells/well were
158
cultured in an opaque 96-well microplate in 200 µL of F12 plus 5% FBS. The next day,
159
the cells were washed with 100 µL of HBSS and treated with monoHAAs (final
160
concentrations of 3 µM IAA, 15 µM BAA, or 300 µM CAA); diHAAs (900 µM DBA,
161
900 µM BCA, or 50 µM DCA); or triHAAs (300 µM TCA, 300 µM CDBA, 500 µM
162
TBA, or 900 µM BDCA) in 50 µL HBSS (supplemented with 1.3 mM CaCl2 and 1.1 mM
163
MgSO4). The microplate was covered with AlumnaSeal and incubated for 4 h at 37°C
164
with 5% CO2. Each experiment contained a concurrent negative control, a
165
bioluminescence background control, HAA-treated cultures, and wells for an ATP
ACS Paragon Plus Environment
9
Environmental Science & Technology
Page 10 of 29
166
standard curve. After 4 h incubation, the cells were washed with 100 µL of HBSS and
167
equilibrated to room temperature for 30 min. The ATP content of the cells was measured
168
according to the manufacturer’s protocol using 50 µL of Cell Titer-Glo ATP reagent.
169
For protein quantification, 3×104 CHO cells/well were cultured in a 96-well flat-
170
bottom clear microplate in 200 µL F12 complete media the day before the experiment.
171
The next day, the cells were treated with the HAAs as described previously for the ATP
172
analysis. After treatment, the protein was quantified in the cell lysates as described in
173
Dad et al. (2013).17
174
PDH Enzyme Kinetics Analysis
175
CHO cells were seeded in 6-well plates at a concentration of 6×106 cells/2 mL of
176
F12 complete medium/well and incubated overnight at 37°C, in a humidified atmosphere
177
of 5% CO2 in air. The following day, the medium was aspirated and the cells were
178
washed twice with 2 mL HBSS at 37°C. The cells were then treated with monoHAAs
179
(final concentration of 3 µM IAA, 15 µM BAA, or 300 µM CAA); diHAAs (900 µM
180
DBA, 900 µM BCA, or 50 µM DCA); or triHAAs (300 µM TCA, 300 µM CDBA, 500
181
µM TBA, or 900 µM BDCA) in HBSS (supplemented with 1.3 mM CaCl2 and 0.5 mM
182
MgCl2) and incubated for 4 h at 37°C. Following the treatment interval, the cells were
183
washed once with HBSS at ambient temperature and harvested with 0.05% trypsin.
184
Harvested cells from different wells treated with the same concentration of each HAA
185
were pooled into a single tube and centrifuged at 16,100 ×g for 1 min; the supernatant
186
was transferred to a new tube.
ACS Paragon Plus Environment
10
Page 11 of 29
187
Environmental Science & Technology
PDH activity was measured using a BioVision PDH colorimetric assay kit. The
188
cell pellets were washed with 500 µL HBSS and homogenized in 200 µL PDH buffer
189
using a motorized tissue grinder (Fisher). Homogenates were incubated on ice for 10 min,
190
followed by centrifugation at 10,000 × g for 5 min at 4°C. A 50 µL sample of the
191
supernatant from each treatment group was transferred to a 96-well microplate, 50 µL of
192
the kit reaction buffer were added to each well, and absorbance was measured
193
immediately with a TUNE-SpectraMax Paradigm® Multi-Mode Microplate Detection
194
Platform (Molecular Devices, Sunnyvale, CA). Measurements were made at 450 nm in
195
kinetic mode for 60 min at 37 °C at 10 min intervals. Each treatment group had three
196
replicates for every experiment and each experiment was repeated at least three times. An
197
NADH standard curve was used to determine the PDH activity as nmol NADH/min/mL
198
using the formula:
199
Sample PDH Activity = B/(∆T × V) × D = nmol/min/mL
200
Where: B = NADH calculated from the standard curve (nmol)
201
∆T = reaction time (min)
202
V = Sample volume in the reaction well (ml)
203
D = Dilution factor
204
The amount of protein measured in each sample was determined using the
205
Bradford assay and was used to calculate nmol NADH/min/mg protein. ANOVA with a
206
Holm-Sidak post-hoc test determined statistical significance among the HAA treatments.
ACS Paragon Plus Environment
11
Environmental Science & Technology
207
Page 12 of 29
RESULTS AND DISCUSSION
208
HAAs as a class of DBPs expressed different levels and types of toxicity,
209
determined by their individual chemical structure.3, 7 The mechanisms responsible for the
210
toxicity of HAAs, and the differences among the molecular targets and toxicity
211
mechanisms of mono-, di-, and triHAAs, are not well understood. Previously, we found
212
that monoHAAs disrupt cellular energy homeostasis by inhibiting GAPDH. It is
213
unknown if di-, and triHAAs share this toxicity mechanism with monoHAAs. We believe
214
that PDH plays a central role in the HAA mechanism of action that leads to disruption in
215
metabolism and cellular energy homeostasis.
216
PDH plays a pivotal role in mitochondrial metabolism as part of a multi-enzyme
217
PDC and produces reducing power for oxidative phosphorylation, thereby linking
218
glycolysis with the citric acid cycle (CAC). 27 The activity of the PDC is regulated by
219
homeostasis in ATP:ADP, NADH:NAD, and Acetyl-CoA :CoA metabolic precursor
220
ratios. 24 In addition to metabolic precursor ratios, PDK and phospho-E1-phosphatase
221
also regulate PDC. 25, 32
222
The E1α component of the tetrameric E1 component is inactivated/phosphorylated
223
by PDK and activated/dephosphorylated by a specific phosphatase, phospho-E1-
224
phosphotase.29, 30 In humans, mutations in the X-linked PDHA1 gene that encodes the
225
E1α subunit result in PDH deficiency disease.40 PDH deficiency disease is characterized
226
by reduced mitochondrial function and is associated with two forms of abnormalities: a
227
metabolic form (lactic acidosis) and a neurological form (neurodevelopment delay and
228
hypotonia). 41 Studies indicate that PDH is also involved in oncogene-induced
ACS Paragon Plus Environment
12
Page 13 of 29
Environmental Science & Technology
229
senescence.34, 42 Activation of PDH enhances pyruvate utilization resulting in increased
230
respiration and redox stress. 34
231
Previous studies indicate that the di-HAA, DCA, inhibits PDK by inducing
232
allosteric changes, resulting in increased PDC activity.32 Thus, DCA was used to activate
233
the PDC to treat different disease states caused by PDH deficiency.43, 44 It was reported
234
that the biotransformation of diHAAs to glyoxylate is dependent on cytosolic glutathione
235
S-transferase-zeta (GST-zeta)45-47. Glyoxylate can undergo transamination,
236
decarboxylation, and oxidation to form glycine, carbon dioxide and oxalate, respectively.
237
DiHAAs can also induce toxicity by generating intermediate compounds. Glyoxylate can
238
induce toxicity by covalently reacting with N-terminal amino groups of proteins or by
239
acting as a suicide substrate for GST-zeta47, 48. Since GST-zeta is identical to
240
maleylacetoacetate isomerase (the enzyme that catalyzes tyrosine catabolism) its diHAA-
241
induced inactivation leads to the buildup of maleylacetoacetate and maleylacetone,
242
which can cause tissue damage due to oxidative stress and by reacting with cellular
243
nucleophiles. Therefore, the use of DCA to cure PDH deficiency potentially can induce
244
toxicity by deactivating tyrosine catabolism, although it is generally regarded as well-
245
tolerated.49, 50
246
When monoHAAs are involved in blocking glycolysis by inhibiting GAPDH,
247
their cytotoxicity and genotoxicity occur through oxidative stress16 resulting from
248
GAPDH inhibition. 18, 51 Addition of pyruvate or treatment with antioxidants relieves cell
249
stress and reduces genotoxicity.17, 52 Stalter et al (2016) demonstrated that HAAs induced
250
oxidative stress, depleted reduced glutathione (GSH) levels, and activated p53, thus
251
confirming indirect HAA-induced DNA damage linked to GAPDH inhibition.53
ACS Paragon Plus Environment
13
Environmental Science & Technology
Page 14 of 29
252
These mechanisms, however, were established with monoHAAs; any differences
253
among the toxicity mechanisms for mono-, di-, and triHAAs are unknown. We postulate
254
that di-, and triHAAs inhibit PDK and activate PDC leading to increased cellular ATP
255
levels. This contrasts with the monoHAAs, IAA and BAA, which are direct inhibitors of
256
GAPDH and greatly reduce ATP levels leading to ATP/ADP ratio disruption that require
257
cells to accelerate the CAC by increasing PDC activity. To test this hypothesis, we
258
analyzed the effect of a series of monoHAAs, diHAAs, and triHAAs on GAPDH
259
kinetics, cellular ATP levels, and PDC activity.
260
Effect of HAAs on GAPDH Kinetics
261
GAPDH is pivotal in glycolysis and plays a crucial role in cellular energy
262
homeostasis. A GAPDH kinetic study measuring NADH levels was performed on
263
homogenates from CHO cells treated with HAAs (monoHAAs: 25 µM IAA, 150 µM
264
BAA, or 5 mM CAA; diHAAs: 2 mM DBA, 2 mM BCA, or 2 mM DCA; or triHAAs: 2
265
mM TCA, 2 mM CDBA, 2 mM TBA, or 2 mM BDCA) for 2 min. The results indicated
266
that the monoHAAs IAA and BAA are strong direct inhibitors of GAPDH (Figure 1).
267
The data in Figure 1 were plotted as the index values of percent of GAPDH inhibition per
268
µM of HAA. The data were normalized as percent reduction of the negative control.
269
Since IAA and BAA were the strongest inhibitors of GAPDH, lower concentrations were
270
used for these two HAAs as compared to other HAAs. To make the comparison among
271
different HAAs more appropriate, the data were normalized based on per µM HAA-
272
induced inhibition. The pairwise comparisons among different HAAs were based on an
273
ANOVA test using the Holm-Sidak method and the analysis is presented in Table 1 of
274
the Supporting Information.
ACS Paragon Plus Environment
14
Page 15 of 29
275
Environmental Science & Technology
Among all the HAAs, IAA was the strongest inhibitor of GAPDH followed by
276
BAA, while CAA was the weakest inhibitor of GAPDH (Figure 1). Comparisons
277
between the alterations to GAPDH kinetics produced by different HAAs indicated that
278
the IAA and BAA induced interference with GAPDH activity was significantly greater
279
than that produced by any of the di- and tri-HAAs (Supporting Information Table 1). The
280
reactivity of IAA vs BAA vs CAA is due to the dissociation energy of the leaving group
281
(the halogen) generating an alkylating product that reacts with the cysteine at the active
282
site of GAPDH15,18. In addition, weaker inhibitory reponses produced by the di-, and
283
triHAAs indicate that they may not interfere with GAPDH, possibly due to the
284
structurally based steric hindrance. Pairwise comparison between most of the di- and tri-
285
HAAs revealed that the reduction in GAPDH activity by these HAAs was not
286
significantly different from each other (Supporting Information, Table 1).
287
The Effect of HAAs on ATP Levels in CHO Cells
288
Our data demonstrated that structurally different HAAs inhibit GAPDH
289
production of NADH to varying degrees and that the monoHAAs, IAA and BAA, were
290
the strongest inhibitors of GAPDH. To study further the associations among structurally
291
different mono-, di-, and triHAAs on cellular energy depletion, we also evaluated the
292
effect HAAs have on cellular ATP levels. Initially, as preliminary experiments, CHO
293
cells were treated with individual HAAs for 4 h at high noncytotoxic concentrations in
294
order to normalize their biological activity on the basis of cytotoxicity (monoHAAs: 4
295
µM IAA, 15 µM BAA, or 700 µM CAA; diHAAs: 700 µM DBA, 700 µM BCA, or 2000
296
µM DCA; and triHAAs: 2000 µM TCA, 1000 µM CDBA, 1000 µM TBA, or 1000 µM
297
BDCA) .12
ACS Paragon Plus Environment
15
Environmental Science & Technology
298
Page 16 of 29
Figure 1 in Supporting Information illustrates the effect of HAAs on ATP levels,
299
expressed as a percent of the concurrent negative control. MonoHAAs induced the
300
greatest reduction in ATP, whereas diHAAs induced a moderate reduction with higher
301
concentration ranges, while triHAAs, except for TCA, induced significant increases in
302
ATP levels. The weaker reduction in ATP levels by diHAAs was expected, as they did
303
not significantly inhibit GAPDH production of NADH, and likely induce energy
304
depletion through a different mechanism than monoHAAs. However, most of the
305
triHAAs (TBA, CDBA, DCBA, but not TCA) induced a significant increase in cellular
306
ATP levels. These observations suggest a general association between cellular ATP level
307
and the number of halogens in the HAA. The results indicated that monoHAAs, including
308
the marginally toxic CAA, significantly reduce ATP levels as compared to concurrent
309
negative controls, and as compared to di-, and triHAAs. The unexpected increase in ATP
310
level produced by most triHAAs suggested that they might have cellular targets involved
311
in the ATP regulatory pathways not shared with the monoHAAs (Figure 1 in
312
Supplemental Information). The association, however, is not absolute (e.g., the TCA
313
response), indicating that various factors, in addition to the number of halogen
314
substituents, influence the toxicity of HAAs.
315
Previous studies demonstrated that DCA and TCA inhibit PDK25, 32 and promote
316
activation of PDC. 25 The decarboxylation of pyruvate into acetyl-CoA by PDC is a rate-
317
limiting step connecting glycolysis to the CAC. Pyruvate decarboxylation by PDC
318
provides substrate (acetyl-CoA) for the CAC. 27 Reports indicated that 1 mM DCA
319
increased the activity of PDC in rat heart by inhibiting PDK, and also showed that there
320
was an inverse relation between the NADH:NAD+, ATP:ADP, and acetyl-CoA:CoA
ACS Paragon Plus Environment
16
Page 17 of 29
Environmental Science & Technology
321
ratios and the activity of PDC.24 Consistent with previous studies, we observed that the
322
monoHAAs, with the exception of CAA, were the strongest inhibitors of GAPDH among
323
all HAAs. Furthermore, monoHAAs including CAA, greatly reduced ATP levels leading
324
to disruptions in ATP:ADP and NADH:NAD+ ratios. Di-, and triHAAs were relatively
325
weaker inhibitors of GAPDH in CHO cells and triHAAs increased ATP levels suggesting
326
a different underlying mechanism for inducing changes in overall cellular metabolism.
327
The CAC and oxidative phosphorylation are pivotal processes in cellular energy
328
homeostasis. Since the CAC is dependent on PDC for its substrate, PDC regulation plays
329
an important role in overall energy homeostasis. Our data demonstrate a general
330
structure-activity relationship for HAA-induced GAPDH inhibition and overall disruption
331
of cellular energy homeostasis, suggesting that differences may exist in the mechanisms
332
exhibited by individual HAAs in modulating PDC activity.
333
Effect of HAAs on PDC Activity
334
Previous studies demonstrated that DCA-induced PDK inhibition activated
335
PDC.32,33 Kato and colleagues found that DCA prevented ADP dissociation from the
336
ATP lid of PDK resulting in PDK inhibition. The presence of DCA and ADP
337
synergistically decreased the affinity of PDK for the L2 domain by 130-fold as compared
338
to ADP alone and eventually affected the L2-induced activation of PDK. The inhibition
339
of PDK by the DCA-induced allosteric change kept the PDC in its active state and
340
accelerated the CAC. 33 Moreover, studies showed that ATP:ADP and NADH:NAD+
341
ratios are also involved in the PDC regulation .24 Therefore, based on these known
342
mechanisms of PDC regulation, we reasoned that IAA and BAA strongly inhibit GAPDH
ACS Paragon Plus Environment
17
Environmental Science & Technology
Page 18 of 29
343
leading to reduced cellular ATP levels that disrupt the ATP:ADP ratio. This altered ratio
344
stimulates cells to activate PDC activity and eventually upregulate the CAC to produce
345
more energy and maintain the ATP:ADP balance. Di-, and triHAAs, however, are weaker
346
inhibitors of GAPDH and some triHAAs increase cellular ATP levels. We further
347
reasoned that di-, and triHAAs may increase ATP levels primarily via PDK inhibition.
348
PDK inhibition leads to increased PDC activity and generates elevated levels of ATP.
349
To test this hypothesis, PDC activity was measured in CHO cells after exposure to
350
structurally different HAAs (Figure 2). We found that most of the HAAs (except for
351
CDBA, BCA and BDCA) increased PDC activity. These data also demonstrated that
352
monoHAAs increased PDC activity to a greater degree than did di- or triHAAs. Among
353
monoHAAs, IAA induced the greatest increase in PDC activity (370% of the negative
354
control), followed by BAA (308%) and CAA (194%) (Figure 2). Previous studies
355
concluded that IAA was the strongest inhibitor of GAPDH and reduced ATP levels to the
356
greatest degree, followed by BAA and CAA.17, 18 It was also revealed that there was an
357
inverse relationship between NADH:NAD+, ATP:ADP, and acetyl-CoA:CoA ratios and
358
PDC activity.24 Our current results with monoHAAs are consistent with these previous
359
findings. The pattern for the increase in PDC activity (IAA > BAA >> CAA) also
360
correlated with the pattern found for other HAA toxicity metrics. 17, 18 Among diHAAs,
361
DCA and DBA increased PDC activity to 135% and 184% above the negative control,
362
respectively, while BCA had no significant effect on PDC activity (Figure 2). Among
363
triHAAs, TBA and TCA increased PDC activity to 255% and 148% of the negative
364
control, respectively. However, BDCA significantly decreased the PDC activity to
365
35.4%, while CDBA had no significant effect on PDC activity. Importantly, these data
ACS Paragon Plus Environment
18
Page 19 of 29
Environmental Science & Technology
366
are generally consistent with our model in which increased PDC activity by the
367
monoHAAs, IAA and BAA is due to disturbances in the metabolite ratios (ATP:ADP,
368
NADH:NAD+) induced by GAPDH inhibition. In contrast, di- and tri-HAAs were weaker
369
inhibitors of GAPDH and had more modest effects on ATP levels (Figure 1 in
370
Supplemental Information), which suggests that the increased PDC activity produced by
371
di- and tri-HAAs is affected by an alternative mechanism, such as the inhibition of PDK.
372
Note that not all HAAs fit these patterns perfectly (e.g., CAA and GAPDH inhibition),
373
indicating that additional mechanisms are probably involved.
374
The purpose of the preliminary experiments indicated in Figure 1 of Supplemental
375
Information was to determine the relationship between the number of halogens in the
376
HAAs and alterations in ATP production. We tested several different concentrations for
377
individual HAAs and chose the lowest noncytotoxic concentration that induced a
378
significant change in ATP reduction for comparing the effects of the different HAAs on
379
ATP production. The lowest concentration of individual HAAs that induced cytotoxicity
380
was published previously. 12 Even though the specific percent ATP change varied by
381
individual HAAs, a general trend was resolved where the mono-HAAs reduced the
382
percent ATP production while tri-HAAs increased percent ATP production. This
383
observation led us to analyze the PDC activity and to repeat the ATP analysis in HAA-
384
treated cells. We demonstrated that the changes in PDC activity correlated with ATP
385
levels based on similar HAA concentrations (Figure 3). We normalized the percent ATP
386
levels per mg protein to serve as more robust values for comparing responses. Moreover,
387
our findings were consistent with our hypothesis regarding HAA-induced effects on PDC
388
activity.
ACS Paragon Plus Environment
19
Environmental Science & Technology
389
Page 20 of 29
MonoHAAs significantly reduced cellular ATP, indicating an inverse relationship
390
between the ATP level and PDC activity. Among the diHAAs, DCA significantly
391
increased cellular ATP to 207.4% as compared to negative control (Figure 3); 50 µM
392
DCA significantly increased the PDC activity as well (Figure 2). Therefore, increases in
393
PDC activity and changes in energy homeostasis by DCA, DBA, TBA, and TCA are not
394
due to changes in the metabolite ratios induced by GAPDH inhibition, but more likely
395
due to allosteric changes induced in PDK by DCA and other di- and tri-HAAs. These
396
changes may lead to inhibition of PDK and activation of PDC, findings that are
397
consistent with previous studies. 24, 32 Furthermore, the relatively strong effect that DCA
398
has on ATP levels and PDC activity may be because it acts as a pyruvate analog, unlike
399
other HAAs54. Significant increases and decreases in the ATP content of HAA-treated
400
cells are shown in Figure 3.
401
In summary, these findings support a model in which the number and type of
402
halogens affect the mechanism and degree of toxicity of HAAs. Our primary finding was
403
that HAAs depending upon their chemical structure affect different molecular target
404
molecules that generate a toxic cascade. Two of the monoHAAs (IAA and BAA)
405
induced their toxicity by indirectly affecting mitochondrial metabolism due to
406
downstream effects of GAPDH inhibition. Di- and triHAAs appeared to affect
407
mitochondrial metabolism by inhibiting PDK, which enhanced PDC activation.
408
Moreover, we found that the monoHAAs strongly affected GAPDH inhibition, ATP
409
depletion and PDC activation whereas di-, and triHAAs produced their effects only at
410
much higher concentrations, which may make their toxicity less relevant to
411
environmental DBP exposures. Di-, and triHAA-induced weaker effects may be due to
ACS Paragon Plus Environment
20
Page 21 of 29
Environmental Science & Technology
412
the steric hindrance induced by the multiple halogen groups in their structures. The
413
relationship between the number of halogens and HAA toxicity, however, was not a
414
perfect one (e.g., CAA, triHAAs). Thus, there are likely to be other factors affecting
415
HAA toxicity that will have to be determined in additional studies.
416
Acknowledgments
417
We appreciate the support of all the funding sources. This work was supported by
418
the EPA STAR Grant R834867. We appreciate support by the Center of Advanced
419
Materials for the Purification of Water with Systems (WaterCAMPWS), a National
420
Science Foundation Science and Technology Center, under Award CTS-0120978. C.J.
421
was supported by a NIEHS Pre-doctoral Fellowship under Grant No. T32 ES007326.
422
ACS Paragon Plus Environment
21
Environmental Science & Technology
Page 22 of 29
References 1. Cutler, D.; Miller, G., The role of public health improvements in health advances: The twentieth-century United States. Demography 2005, 42, (1), 1-22. 2. Richardson, S. D.; Postigo, C., Formation of DBPs: State of the Science. In Recent Advances in Disinfection By-Products, American Chemical Society: 2015; Vol. 1190, pp 189-214. 3. Richardson, S. D.; Plewa, M. J.; Wagner, E. D.; Schoeny, R.; Demarini, D. M., Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection byproducts in drinking water: a review and roadmap for research. Mutat. Res. Rev. Mutat. Res. 2007, 636, (1-3), 178-242. 4. Krasner, S. W.; Weinberg, H. S.; Richardson, S. D.; Pastor, S. J.; Chinn, R.; Sclimenti, M. J.; Onstad, G. D.; Thruston Jr, A. D., Occurrence of a new generation of disinfection byproducts. Environ. Sci. Technol. 2006, 40, (23), 7175-7185. 5. Krasner, S. W., The formation and control of emerging disinfection by-products of health concern. Philos. Trans. A. Math. Phys. Eng. Sci. 2009, 367, (1904), 4077-95. 6. U. S. Environmental Protection Agency, National Primary Drinking Water Regulations; Stage 2 Disinfectants and Disinfection Byproducts Rule. Fed Reg 2006, 71, (2), 387-493. 7. Plewa, M. J.; Kargalioglu, Y.; Vankerk, D.; Minear, R. A.; Wagner, E. D., Mammalian cell cytotoxicity and genotoxicity analysis of drinking water disinfection byproducts. Environ. Mol. Mutagen. 2002, 40, (2), 134-142. 8. Narotsky, M. G.; Best, D. S.; McDonald, A.; Godin, E. A.; Hunter, E. S., 3rd; Simmons, J. E., Pregnancy loss and eye malformations in offspring of F344 rats following gestational exposure to mixtures of regulated trihalomethanes and haloacetic acids. Reprod. Toxicol. 2011, 31, (1), 59-65. 9. Villanueva, C. M.; Cantor, K. P.; Grimalt, J. O.; Malats, N.; Silverman, D.; Tardon, A.; Garcia-Closas, R.; Serra, C.; Carrato, A.; Castaño-Vinyals, G.; Marcos, R.; Rothman, N.; Real, F. X.; Dosemeci, M.; Kogevinas, M., Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am. J. Epidemiol. 2007, 165, (2), 148-156. 10. Waller, K.; Swan, S. H.; DeLorenze, G.; Hopkins, B., Trihalomethanes in drinking water and spontaneous abortion. Epidemiology 1998, 9, (2), 134-140. 11. National Toxicology Program Toxicity Effects. https://tools.niehs.nih.gov/cebs3/ntpviews/index.cfm?action=testarticle.toxicity&cas_nu mber=79-43-6 12. Plewa, M. J.; Simmons, J. E.; Richardson, S. D.; Wagner, E. D., Mammalian Cell Cytotoxicity and Genotoxicity of the Haloacetic Acids, A Major Class of Drinking Water Disinfection By-Products. Environ. Mol. Mutagen. 2010, 51, (8-9), 871-878. 13. Kargalioglu, Y.; McMillan, B. J.; Minear, R. A.; Plewa, M. J., Analysis of the cytotoxicity and mutagenicity of drinking water disinfection by-products in Salmonella typhimurium. Teratog. Carcinog. Mutagen. 2002, 22, (2), 113-28. 14. Zhang, S. H.; Miao, D. Y.; Liu, A. L.; Zhang, L.; Wei, W.; Xie, H.; Lu, W. Q., Assessment of the cytotoxicity and genotoxicity of haloacetic acids using microplatebased cytotoxicity test and CHO/HGPRT gene mutation assay. Mutat. Res. 2010, 703, (2), 174-9.
ACS Paragon Plus Environment
22
Page 23 of 29
Environmental Science & Technology
15. Plewa, M. J.; Wagner, E. D.; Richardson, S. D.; Thruston, A. D., Jr.; Woo, Y. T.; McKague, A. B., Chemical and biological characterization of newly discovered iodoacid drinking water disinfection byproducts. Environ. Sci. Technol. 2004, 38, (18), 4713-22. 16. Pals, J.; Attene-Ramos, M. S.; Xia, M.; Wagner, E. D.; Plewa, M. J., Human cell toxicogenomic analysis links reactive oxygen species to the toxicity of monohaloacetic acid drinking water disinfection byproducts. Environ. Sci. Technol. 2013, 47, (21), 12514-12523. 17. Dad, A.; Jeong, C. H.; Pals, J. A.; Wagner, E. D.; Plewa, M. J., Pyruvate remediation of cell stress and genotoxicity induced by haloacetic acid drinking water disinfection by-products. Environ. Mol. Mutagen. 2013, 54, (8), 629-37. 18. Pals, J. A.; Ang, J. K.; Wagner, E. D.; Plewa, M. J., Biological mechanism for the toxicity of haloacetic acid drinking water disinfection byproducts. Environ. Sci.Technol. 2011, 45, (13), 5791-5797. 19. Butterfield, D. A.; Hardas, S. S.; Lange, M. L. B., Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and alzheimer's disease: Many pathways to neurodegeneration. J. Alzheimers Dis. 2010, 20, (2), 369-393. 20. Jenkins, J. L.; Tanner, J. J., High-resolution structure of human Dglyceraldehyde-3-phosphate dehydrogenase. Acta. Crystallogr. D. Biol. Crystallogr. 2006, 62, (3), 290-301. 21. Fouque, F. o.; Brivet, M.; Boutron, A.; Vequaud, C.; Marsac, C. c.; Zabot, M.-T. r. s.; Benelli, C., Differential Effect of DCA Treatment on the Pyruvate Dehydrogenase Complex in Patients with Severe PDHC Deficiency. Pediatr. Res. 2003, 53, (5), 793-799. 22. Dhar, S.; Lippard, S. J., Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, (52), 22199-22204. 23. Itoh, Y.; Esaki, T.; Shimoji, K.; Cook, M.; Law, M. J.; Kaufman, E.; Sokoloff, L., Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, (8), 4879-84. 24. Kerbey, A. L.; Randle, P. J.; Cooper, R. H.; Whitehouse, S.; Pask, H. T.; Denton, R. M., Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide. Biochem. J. 1976, 154, (2), 327-48. 25. Whitehouse, S.; Cooper, R. H.; Randle, P. J., Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem. J. 1974, 141, (3), 761-774. 26. De Marcucci, O.; Lindsay, J. G., Component X. An immunologically distinct polypeptide associated with mammalian pyruvate dehydrogenase multi-enzyme complex. Eur J Biochem. 1985, 149, (3), 641-8. 27. Tymoczko, J. L.; Berg, J. M.; Stryer, L., Biochemistry; a short course. In 2nd ed.; W. H. Freeman and Company: Houndmills, Basingstoke RG21 6XS, England, 2013; p 683. 28. Jilka, J. M.; Rahmatullah, M.; Kazemi, M.; Roche, T. E., Properties of a newly characterized protein of the bovine kidney pyruvate dehydrogenase complex. J. Biol. Chem. 1986, 261, (4), 1858-67.
ACS Paragon Plus Environment
23
Environmental Science & Technology
Page 24 of 29
29. Patel, M. S.; Roche, T. E., Molecular biology and biochemistry of pyruvate dehydrogenase complexes. Fed. Am. Soc. Exp. Biol. 1990, 4, (14), 3224-33. 30. Frey, P. A.; Flournoy, D. S.; Gruys, K.; Yang, Y. S., Intermediates in reductive transacetylation catalyzed by pyruvate dehydrogenase complex. Ann. N. Y. Acad. Sci. 1989, 573, 21-35. 31. Patel, M. S.; Korotchkina, L. G., The biochemistry of the pyruvate dehydrogenase complex*. Biochem. Mol. Biol. Educ 2003, 31, (1), 5-15. 32. Kato, M.; Chuang, J. L.; Tso, S. C.; Wynn, R. M.; Chuang, D. T., Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex. The EMBO journal 2005, 24, (10), 1763-74. 33. Kato, M.; Li, J.; Chuang, J. L.; Chuang, D. T., Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol. Structure 2007, 15, (8), 992-1004. 34. Bonnet, S.; Archer, S. L.; Allalunis-Turner, J.; Haromy, A.; Beaulieu, C.; Thompson, R.; Lee, C. T.; Lopaschuk, G. D.; Puttagunta, L.; Bonnet, S.; Harry, G.; Hashimoto, K.; Porter, C. J.; Andrade, M. A.; Thebaud, B.; Michelakis, E. D., A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth. Cancer Cell 2007, 11, (1), 37-51. 35. Berg, J. M.; Tymoczko, J. L.; Stryer, L., Entry to the Citric Acid Cycle and Metabolism Through It Are Controlled. . In Biochemistry, 5th edition ed.; W H Freeman: New York, 2002. 36. Wagner, E. D.; Plewa, M. J., CHO cell cytotoxicity and genotoxicity analyses of disinfection by-products: an updated review. . J. Environ. Sci. 2017, Submitted. 37. Tindall, K. R.; Stankowski Jr, L. F., Molecular analysis of spontaneous mutations at the gpt locus in Chinese hamster ovary (AS52) cells. Mutat. Res. 1989, 220, (2-3), 241253. 38. Wagner, E. D.; Rayburn, A. L.; Anderson, D.; Plewa, M. J., Analysis of mutagens with single cell gel electrophoresis, flow cytometry, and forward mutation assays in an isolated clone of Chinese hamster ovary cells. Environ. Mol. Mutagen. 1998, 32, (4), 360368. 39. Wagner, E. D.; Rayburn, A. L.; Anderson, D.; Plewa, M. J., Calibration of the single cell gel electrophoresis assay, flow cytometry analysis and forward mutation in Chinese hamster ovary cells. Mutagenesis 1998, 13, (1), 81-84. 40. Lissens, W.; De Meirleir, L.; Seneca, S.; Liebaers, I.; Brown, G. K.; Brown, R. M.; Ito, M.; Naito, E.; Kuroda, Y.; Kerr, D. S.; Wexler, I. D.; Patel, M. S.; Robinson, B. H.; Seyda, A., Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum. Mutat. 2000, 15, (3), 209-19. 41. Patel, K. P.; O'Brien, T. W.; Subramony, S. H.; Shuster, J.; Stacpoole, P. W., The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol. Genet. Metab. 2012, 106, (3), 385-94. 42. Kaplon, J.; Zheng, L.; Meissl, K.; Chaneton, B.; Selivanov, V. A.; Mackay, G.; van der Burg, S. H.; Verdegaal, E. M.; Cascante, M.; Shlomi, T.; Gottlieb, E.; Peeper, D. S., A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013, 498, (7452), 109-12.
ACS Paragon Plus Environment
24
Page 25 of 29
Environmental Science & Technology
43. Stacpoole , P. W.; Moore , G. W.; Kornhauser , D. M., Metabolic Effects of Dichloroacetate in Patients with Diabetes Mellitus and Hyperlipoproteinemia. N. Engl. J. Med. 1978, 298, (10), 526-530. 44. Li, C.; Meng, G.; Su, L.; Chen, A.; Xia, M.; Xu, C.; Yu, D.; Jiang, A.; Wei, J., Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma. Oncotarget 2015, 6, (3), 1544-1555. 45. James, M. O.; Cornett, R.; Yan, Z.; Henderson, G. N.; Stacpoole, P. W., Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetatetreated rats. Drug Metab Dispos 1997, 25, (11), 1223-7. 46. Tong, Z.; Board, P. G.; Anders, M. W., Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol 1998, 11, (11), 1332-8. 47. Anderson, W. B.; Board, P. G.; Anders, M. W., Glutathione transferase zetacatalyzed bioactivation of dichloroacetic acid: reaction of glyoxylate with amino acid nucleophiles. Chem Res Toxicol 2004, 17, (5), 650-62. 48. Anderson, W. B.; Board, P. G.; Gargano, B.; Anders, M. W., Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alphahaloalkanoic acids. Chem Res Toxicol 1999, 12, (12), 1144-9. 49. Ammini, C. V.; Fernandez-Canon, J.; Shroads, A. L.; Cornett, R.; Cheung, J.; James, M. O.; Henderson, G. N.; Grompe, M.; Stacpoole, P. W., Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents. Biochem Pharmacol 2003, 66, (10), 2029-38. 50. Blackburn, A. C.; Matthaei, K. I.; Lim, C.; Taylor, M. C.; Cappello, J. Y.; Hayes, J. D.; Anders, M. W.; Board, P. G., Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol 2006, 69, (2), 650-7. 51. Kahlert, S.; Reiser, G., Requirement of glycolytic and mitochondrial energy supply for loading of Ca2+ stores and InsP(3)-mediated Ca2+ signaling in rat hippocampus astrocytes. J. Neurosci. Res. 2000, 61, (4), 409-420. 52. Cemeli, E.; Wagner, E. D.; Anderson, D.; Richardson, S. D.; Plewa, M. J., Modulation of the cytotoxicity and genotoxicity of the drinking water disinfection byproduct lodoacetic acid by suppressors of oxidative stress. Environ. Sci. Technol. 2006, 40, (6), 1878-83. 53. Stalter, D.; O'Malley, E.; von Gunten, U.; Escher, B. I., Fingerprinting the reactive toxicity pathways of 50 drinking water disinfection by-products. Water Res 2016, 91, 19-30. 54. Saunier, E.; Benelli, C.; Bortoli, S., The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents. Int. J. Cancer 2016, 138, (4), 809-17.
ACS Paragon Plus Environment
25
Environmental Science & Technology
Page 26 of 29
FIGURES
GAPDH kinetics inhibition induced by per µM HAAs (Index values (±SE))
100
80
60
40
20
0 IAA
BAA
CAA
BCA
DBA
DCA
TBA
TCA CDBA BDCA
Treatment Group [HAAs]
Figure 1. Percent reduction in GAPDH activity per µM of different HAAs as measured by NADH production. Among all the HAAs, the monoHAAs (red, specifically, IAA and BAA) were the strongest inhibitors of GAPDH activity, whereas CAA, di- (green), and tri-HAAs (blue) had more modest or no effects. Abbreviations: CAA, chloroacetic acid; BAA, bromoacetic acid; IAA, iodoacetic acid; DCA, dichloroacetic acid; DBA, dibromoacetic acid; BCA, bromochloroacetic acid; TCA, trichloroacetic acid; TBA, tribromoacetic acid; BDCA, bromodichloroacetic acid; CDBA, dibromochloroacetic acid
ACS Paragon Plus Environment
26
Environmental Science & Technology
500
*
400
* *
300
*
*
*
200
* * 0
TC A
50
50 0 C µM D BA 30 0 BD µM C A 30 0 µM
µM
µM 90
0 TB A
D
A
BA
90 0
µM
µM 50 BC
D C
A
15
µM C AA
15
3 IA A
iv e eg at N
BA A
nt
µM
ro l
0
µM
100
co
PDC Activity as nmol of NADH/min/mg protein as Percent of the Concurrent Negative Control (±SE)
Page 27 of 29
Treatment Groups [HAA]
Figure 2. Effect of HAAs on CHO PDC activity (nmol NADH/min/mg protein). PDC activity for each HAA treatment group was normalized against each concurrent negative control and the negative control shown here is the average of all the negative control groups. The * indicates a statistically significant difference from the concurrent negative control, SE is standard error.
Abbreviations: CAA, chloroacetic acid; BAA, bromoacetic acid; IAA, iodoacetic acid; DCA, dichloroacetic acid; DBA, dibromoacetic acid; BCA, bromochloroacetic acid; TCA, trichloroacetic acid; TBA, tribromoacetic acid; BDCA, bromodichloroacetic acid; CDBA, dibromochloroacetic acid
ACS Paragon Plus Environment
27
Environmental Science & Technology
Page 28 of 29
pmol ATP/mg Protein Normalized with Concurrent Negative Control (±SE)
250
* 200
150
100
*
*
* *
50
50 0 µM TC A 50 0 C µM D BA 30 BD 0 µM C A 30 0 µM
µM
TB A
90
0
D BA
A
90 0
µM
µM 50 BC
D
C A
µM
µM
30 0
3
15
C AA
BA A
IA A
N eg at iv e
C on
tro
µM
l
0
Treatment Groups [HAA]
Figure 3. Effect of HAAs on cellular ATP levels (pmol ATP/mg protein). ATP levels for each HAA treatment group are expressed as a percent of the concurrent negative control; the negative control shown here is the average of all the negative control groups. * indicates a statistically significant difference from the negative control, SE is standard error. Abbreviations: CAA, chloroacetic acid; BAA, bromoacetic acid; IAA, iodoacetic acid; DCA, dichloroacetic acid; DBA, dibromoacetic acid; BCA, bromochloroacetic acid; TCA, trichloroacetic acid; TBA, tribromoacetic acid; BDCA, bromodichloroacetic acid; CDBA, dibromochloroacetic acid
ACS Paragon Plus Environment
28
Page 29 of 29
Environmental Science & Technology
187x98mm (300 x 300 DPI)
ACS Paragon Plus Environment